EVENT / PUBLIC SOURCE RECORD
Scale with Laerdal in the US Healthtech market
- Ongoing trade-mission programme scheduled 28 January 2026–1 January 2027, based in New York. Innovation Norway and Laerdal established it for Norwegian healthtech companies seeking international growth, combining Laerdal’s hospital-innovation experience with access to US institutions including Mayo Clinic and Tanner Health.
- Four phases: (1) assess US-market relevance/readiness for 15 selected Norwegian companies; (2) conduct 2–4 digital/in-person workshops with US hospital representatives and assess regulatory, commercial, product, financial, and operational gaps; (3) invite 4–6 companies to US market visits and pilot/co-creation projects with hospitals, with funding support and EHR-integration preparation; (4) accelerate market entry through Laerdal networks, customer access, scaling strategies, and long-term partnerships.
- The page describes the US as a large healthtech market and highlights clinical-network access, hospital-system insight, validation/co-creation opportunities, and a structured route to scaling. It states annual healthcare spending of USD 4.3 trillion (18% of GDP), employment above 20 million, and a 65+ population projected to rise from 55 million to 73 million by 2030. Contacts: John Vislosky, Senior Advisor Health Tech, New York (john.vislosky@innovationnorway.no); Tone Varslot Stave, Head of Innovation Norway’s national export initiative on health and life science (tone.varslot.stave@innovasjonnorge.no). Partners: Laerdal and Innovation Norway.